GeneDX Slides on Asserting Industry Leadership Role
GeneDx (NASDAQ: WGS) shares fell Wednesday. The company, a leader in delivering improved health outcomes through genomic insights, continues its investment in advancing scientific discovery through understanding gene-disease relationships, contributing to more than 85 peer-reviewed publications in 2024. These contributions, added to GeneDx’s years of dedicated research efforts, influenced the broadening of phenotypes, the discovery…